Skip to main content

Want a detailed portfolio tracker?

Evogene (EVGN) P/E (2012 - 2026)

Evogene (EVGN) P/E from Jan 3, 2012 to Jul 20, 2026. The TTM Evogene (EVGN) P/E is -0.91. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Evogene (EVGN)

YearP/EChange
2026-0.91-49.53%
2025-1.81-106.11%
202429.55-386.22%
2023-10.33-82.29%
2022-58.31-57.32%
2021-136.61-65.11%
2020-391.50+209.21%
2019-126.61-23.23%
2018-164.93-35.50%
2017-255.72-39.80%
2016-424.82-36.65%
2015-670.54-12.60%
2014-767.17-53.13%
2013-1.64K-36.91%
2012-2.59KN/A

Comparison Evogene (EVGN) P/E with competitors

Evogene (EVGN) P/E is -0.91.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.19%
NBYStablecoin Development Corp0.00-100.47%
ENLVEnlivex Ltd0.07-108.21%
FGENFibroGen Inc0.24-126.33%
CHRSCoherus Biosciences Inc0.85-193.09%
FBIOFortress Biotech Inc0.95-204.12%
ORMPOramed Pharmaceuticals Inc1.50-264.90%
AGENAgenus Inc3.01-430.18%
INVAInnoviva Inc3.15-446.03%
VXRTVaxart Inc3.55-489.44%
CRMDCorMedix Inc3.63-498.07%
CVACCureVac N.V.4.45-587.73%
GLPGGalapagos NV4.86-633.07%
SRPTSarepta Therapeutics Inc4.88-635.61%
ABEOAbeona Therapeutics Inc5.39-691.06%
ABUSArbutus Biopharma Corp5.60-713.89%
ZVRAZevra Therapeutics Inc5.89-745.88%
SPROSpero Therapeutics Inc6.23-783.32%
CGENCompugen Ltd6.31-792.70%
RIGLRigel Pharmaceuticals6.87-853.93%
SLXNSilexion Therapeutics Corp7.30-900.45%
OMEROmeros Corporation9.26-1115.77%
AUPHAurinia Pharmaceuticals Inc9.58-1151.56%
PLXProtalix BioTherapeutics Inc10.89-1294.85%
ACADAcadia Pharmaceuticals Inc11.73-1386.73%
TBPHTheravance Biopharma Inc12.26-1445.27%
ADMAAdma Biologics Inc12.42-1462.39%
HRMYHarmony Biosciences Holdings Inc13.82-1616.21%
SABSSAB Biotherapeutics Inc14.14-1650.88%
NAGENiagen Bioscience Inc14.82-1725.69%
INCYIncyte Corp15.82-1835.89%
REGNRegeneron Pharmaceuticals Inc15.86-1839.63%
PBYIPuma Biotechnology Inc17.32-1999.70%
CPRXCatalyst Pharmaceuticals Inc17.44-2013.26%
EXELExelixis Inc17.54-2024.09%
TGTXTG Therapeutics Inc18.97-2180.76%
MDXGMimedx Group Inc20.55-2354.81%
XOMAXOMA Royalty Corp22.87-2609.64%
ARGXArgen X SE24.30-2765.80%
CTMXCytomX Therapeutics Inc24.82-2823.19%
XOMAOXOMA Royalty Corp25.34-2880.65%
HALOHalozyme Therapeutics Inc25.62-2911.25%
XOMAPXOMA Royalty Corp25.67-2916.34%
VRTXVertex Pharmaceuticals Inc27.99-3171.38%
RPRXRoyalty Pharma plc - Class A28.69-3247.39%
SLNOSoleno Therapeutics Inc29.02-3283.35%
ASNDAscendis Pharma A/S30.09-3400.77%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4259.43%
APLSApellis Pharmaceuticals Inc39.02-4381.12%
BMRNBiomarin Pharmaceutical Inc42.21-4731.17%
KRYSKrystal Biotech Inc45.34-5074.75%
ONCBeiGene Ltd69.54-7729.47%
PHARPharming Group N.V.75.03-8331.26%
TECHBio-Techne Corp101.96-11286.13%
VCELVericel Corp109.92-12159.77%
ALNYAlnylam Pharmaceuticals Inc117.96-13042.27%
GMABGenmab140.29-15491.68%
TLXTelix Pharmaceuticals Ltd162.15-17890.23%
CORTCorcept Therapeutics Inc212.86-23453.18%